Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has received a landmark £80 million donation from the Reuben Foundation that will transform Oxford’s newest college and establish a major new scholarship programme for graduate and undergraduate students.

Reuben College located in Oxford © Alison Stibbe

The University last year established its 39th college – the first for 30 years – as a new base for graduate students who are eager to embrace opportunities for interdisciplinary exchange and apply their research to address key future challenges. Initially named Parks College for its location on Parks Road, the college is now set to become ‘Reuben College’, in recognition of the historic gift that secures its vision of a diverse, dynamic research community working on some of the key issues of our time.

Due to welcome its first students in the autumn of 2021, Reuben College has already attracted an outstanding line-up of academic Fellows. The college aims to generate new insights into the biggest questions of our time by bringing academics from traditionally different disciplines together to work on challenging themes and share their knowledge with the college’s graduate students. A culture of innovation and enterprise and a strong commitment to diversity, sustainability and public engagement will cut across all interdisciplinary activities. The college’s initial research themes are: Artificial Intelligence and Machine Learning; Environmental Change; and Cellular Life, which includes ongoing work in understanding COVID-19 and the current pandemic.

Read more on the University of Oxford website

Similar stories

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.